Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2020

Shah MA, Mayer S, Emlen F, Sholle E, Christos P, Cushing M, et al. Clinical Screening for COVID-19 in Asymptomatic Patients With Cancer. JAMA Netw Open. 2020;3(9):e2023121.

Deva AK, Turner SD, Kadin ME, Magnusson MR, H Prince M, Miranda RN, et al. Etiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Current Directions in Research. Cancers (Basel). 2020;12(12).

Viswanathan K, Roboz G, Chadburn A, Mathew S. Chronic Myelogenous Leukemia Diagnosed in the Setting of Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. Int J Surg Pathol. 2020;28(2):216-224.

Lopez A, Trager MH, Magro C, Geskin LJ. Collisional variant of CD8 mycosis fungoides and indolent CD8 lymphoid proliferation. JAAD Case Rep. 2020;6(9):921-924.

Bhargava HK, Leo P, Elliott R, Janowczyk A, Whitney J, Gupta S, et al. Computationally Derived Image Signature of Stromal Morphology Is Prognostic of Prostate Cancer Recurrence Following Prostatectomy in African American Patients. Clin Cancer Res. 2020;26(8):1915-1923.

Cheleuitte-Nieves C, Heselpoth RD, Westblade LF, Lipman NS, Fischetti VA. Searching for a Bacteriophage Lysin to Treat in Immunocompromised Mice. Comp Med. 2020;70(4):328-335.

Yang HS, Racine-Brzostek SE, Lee WT, Hunt D, Yee J, Chen Z, et al. SARS-CoV-2 antibody characterization in emergency department, hospitalized and convalescent patients by two semi-quantitative immunoassays. Clin Chim Acta. 2020;509:117-125.

Prutsch N, Gurnhofer E, Suske T, Liang HC, Schlederer M, Roos S, et al. Correction: Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphoma. Leukemia. 2020;34(11):3105.

Chung HH, Morjaria S, Frame J, Riley M, Zhang AW, Martin SC, et al. Rethinking the need for a platelet transfusion threshold of 50 × 10 /L for lumbar puncture in cancer patients. Transfusion. 2020;60(10):2243-2249.

Schatz-Siemers N, Chen Y-, Chen Z, Wang D, Ellenson LH, Du Y-. Expression of the Receptor for Hyaluronic Acid-Mediated Motility (RHAMM) in Endometrial Cancer is Associated With Adverse Histologic Parameters and Tumor Progression. Appl Immunohistochem Mol Morphol. 2020;28(6):453-459.